The expression and concentrations of Fas/APO-1 (CD95) antigen in patients with severe pre-eclampsia

Journal of Reproductive Immunology

Volumn 49, Issue 2, 2001, Pages 153-164

  Darmochwal Kolarz, Dorota ^a   Leszczynska Gorzelak, Bozena ^a   Rolinski, Jacek ^a   Oleszczuk, Jan ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Apoptosis; Fas antigen; Flow cytometry; Lymphocytes; Pre eclampsia

Indexed keywords

CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PREECLAMPSIA; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD95; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; FAS LIGAND PROTEIN; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; PRE-ECLAMPSIA; PREGNANCY;

EID: 0035138635     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(00)00086-3     Document Type: Article

References (38)

1. Immunologic parameters in women with normal pregnancy and pre-eclampsia
2. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
3. Maternal aggression against placenta
4. Expression of the nonclassic histocompatibility antigen HLA-G by pre-eclamptic placenta
5. + lymphocytes in pregnant women with pre-eclampsia
6. T helper 1 type and T helper 2 type cytokine imbalance in pregnant women with pre-eclampsia
7. HLA antigens-antibodies system and its association with severe toxemia of pregnancy
8. The role of FasL-induced apoptosis in immune privilege
9. Pathogenic implications of interleukin-2 expressed in pre-eclamptic decidual tissues. A possible mechanism of deranged vasculature of the placenta associated associated with pre-eclampsia
10. Elevated serum soluble FAS/APO-1 in pre-eclampsia
11. Amniotic fluid soluble FAS levels are elevated in intra-amniotic infection (IAI)
12. Expression of FasL by pre-eclamptic placenta
13. Serum levels of soluble Fas/APO-1 (CD95) molecule and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases
14. + u kobiet w wybranych stanach patologii ciaży
15. Uterine NK cells and trophoblast HLA class I molecules
16. A class I antigen HLA-G, expressed in human trophoblast
17. Fas and FasL in the homeostatic regulation of immune responses
18. T lymphocyte subpopulations and lymphocyte proliferative activity in normal and pre-eclamptic pregnancy
19. Cell-mediated immunity imbalance in pregnancy induced hypertension
20. A role of the cell death factor system (Fas/FasL) in spontaneous rupture of membranes
21. Immune recognition at the maternal-fetal interface: overview
22. Fas-Fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease
23. The Fas death factor
24. Studies of natural killer cells in pregnancy induced hypertension
25. Social controls on cell survival and cell death
26. Immunological aspects of pre-eclampsia
27. Pre-eclampsia: an excessive maternal inflamatory resonse to pregnancy
28. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
29. Fetomaternal tolerance: role of HLA-G molecule in the protection of the fetus against maternal natural killer activity
30. Expression of Fas ligand by human cytotrophoblast: implication in placentation and fetal survival
31. Normal pregnancy and pre-eclampsia both produce inflamatory changes in peripheral blood leukocytes akin to those of sepsis
32. Indreased T-Helper-1-type immunity and decreased T-Helper-2-type immunity in patients with preeclampsia
33. Cellular immunity in pregnancy induced hypertensive diseases
34. Expression of the Fas and Fas ligand in cells of T cell lineage
35. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion
36. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen
37. Death gets a break
38. Cell death: the significance of apoptosis